AQR Capital Management’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-7,249
| Closed | -$954K | – | 2319 |
|
|
2020
Q4 | $954K | Sell |
7,249
-6,274
| -46% | -$826K | ﹤0.01% | 1527 |
|
|
2020
Q3 | $683K | Sell |
13,523
-2,526
| -16% | -$128K | ﹤0.01% | 1596 |
|
|
2020
Q2 | $765K | Sell |
16,049
-3,033
| -16% | -$145K | ﹤0.01% | 1583 |
|
|
2020
Q1 | $935K | Buy |
19,082
+3,526
| +23% | +$173K | ﹤0.01% | 1358 |
|
|
2019
Q4 | $893K | Buy |
15,556
+4,217
| +37% | +$242K | ﹤0.01% | 1552 |
|
|
2019
Q3 | $408K | Buy |
+11,339
| New | +$408K | ﹤0.01% | 1815 |
|